Pure Global AI
NCT06414473Not yet recruiting

CBD for Knee Osteoarthritis

Sub-Lingual Administration of Cannabidiol for Knee Osteoarthritis
University of FloridaPhase 1/2ClinicalTrials.govdrug
Verified
Study focus
Disease/Condition
Osteoarthritis, Knee
Drug/Device/Intervention
Cannabidiol (CBD) Extract
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
University of Florida
Timeline & enrollment
Phase
Phase 1/2
Start date
Jun 01, 2024
End date
Dec 31, 2026
Enrollment
30 participants
Primary outcome

Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE),Theoretical Framework of Acceptability Questionnaire (TFAQ),Self-report Ratings of Knee Pain,Physical Activity,Western Ontario and McMaster Universities Arthritis Index (WOMAC)

Summary

Osteoarthritis is a disease that affects millions of Americans and is the leading cause of
 persistent pain and physical disability in the older adult population. Many physically active
 Americans have reported pain-relieving effects of cannabidiol (CBD) that can reduce or
 eliminate use of nonsteroidal anti-inflammatory drugs (NSAIDs) for activity-related pain with
 minimal to no side effects. Long-term use of over-the-counter medications, including NSAIDs,
 can pose a significant health risk, and therefore clinical research on the safety and
 efficacy of CBD is needed.

ICD-10 classifications
Chronic instability of kneeInjuries to the knee and lower legGonarthrosis [arthrosis of knee]Dislocation, sprain and strain of joints and ligaments of kneeSprain and strain of other and unspecified parts of knee
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06414473
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06414473 through Pure Global AI's free database. This Phase 1/2 trial is sponsored by University of Florida and is currently Not yet recruiting. The study focuses on Osteoarthritis, Knee. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.